Categories·Healthcare·Medical Devices

Diagnostic Devices

Stocks

By market cap · 57 stocks

  1. 1ABTAbbottFreeStyle Libre, cardiovascular devices, diagnostics, and nutrition$178.18B+1.03%
  2. 2DHRDanaherBioprocessing, life-science, and clinical diagnostics portfolio$151.67B+1.14%
  3. 3NTRANateraMolecular testing across pregnancy, cancer, and organ health$53.08B+3.25%
  4. 4ILMNIlluminaSequencing and array platform with recurring consumables$36.13B+2.05%
  5. 5DGXQuest DiagnosticsClinical testing and diagnostic laboratory network$27.03B−4.67%
  6. 6PHGPhilips (ADR)Clinical imaging, connected care, and personal health$24.34B+0.24%
  7. 7GHGuardant HealthCancer blood tests for screening, monitoring, and treatment$23.33B+2.44%
  8. 8RVTYRevvityLife-science research and clinical diagnostics supplier$16.02B+0.07%
  9. 9TWSTTwist BioscienceSilicon-based DNA synthesis and sequencing tools$10.33B+2.63%
  10. 10BIOBio-Rad LaboratoriesDroplet digital PCR and clinical-lab systems$10.16B+0.32%
  11. 11QGENQIAGENSample-to-Insight molecular testing workflow provider$9.24B−1.76%
  12. 12GRFSGrifols (ADR)Integrated plasma therapies and diagnostics$6.23B+0.75%
  13. 13MMEDMiniMed GroupIntegrated insulin delivery and glucose monitoring$5.93B−0.27%
  14. 14HAEHaemoneticsPlasma collection and hospital blood-management devices$4.94B+0.19%
  15. 15BLLNBillionToOneMaker of prenatal and cancer genetic tests$4.78B+8.18%
  16. 16GRALGRAILDeveloper of Galleri multi-cancer blood screening$4.63B−2.21%
  17. 17ADPTAdaptive BiotechnologiesImmune-receptor sequencing for residual-disease testing$4.46B−2.24%
  18. 18CELCCelcuityDeveloper of REVTORPYK for advanced breast cancer$4.10B−1.48%
  19. 19VCYTVeracyteGenomic cancer tests from diagnosis through recurrence$3.31B+2.59%
  20. 20ALMRAlamar BiosciencesNULISA-based precision proteomics platform provider$2.43B+0.68%
  21. 21OPKOPKO HealthBioReference diagnostics and biopharma operator$1.26B+2.05%
  22. 22CBLLCeribellMaker of a bedside AI seizure-detection headband$920.1M+0.32%
  23. 23QDELQuidelOrthoDiagnostics maker behind VITROS analyzers and Sofia tests$740.6M+1.04%
  24. 24FLGTFulgent GeneticsGenetic-testing lab pairing diagnostics with a cancer-drug pipeline$611.7M+0.74%
  25. 25PREPrenetics GlobalIM8 supplements and CircleDNA consumer testing$413.8M−3.66%
  26. 26MYGNMyriad GeneticsBRCA-rooted molecular diagnostics portfolio$378.7M−0.37%
  27. 27CVCapsoVisionPanoramic capsule endoscopy for small-bowel imaging$309.3M−2.26%
  28. 28OSUROraSure TechnologiesOraQuick tests and sample-management devices$254.1M+5.28%
  29. 29NNNNAnbio BiotechnologyDesigner of decentralized diagnostic testing platforms$249.3M−2.78%
  30. 30BDSXBiodesixBlood-based lung diagnostics and development services$231.4M+1.27%
  31. 31XGNExagenAVISE diagnostics for autoimmune disease assessment$208.3M+1.99%
  32. 32TRIBTrinity Biotech (ADR)Diagnostics maker for HIV and haemoglobin testing$148.8M−1.22%
  33. 33FRNMFreenomeMultiomic blood tests for early cancer screening$135.4M−0.36%
  34. 34STXSStereotaxisRobotic magnetic navigation for cardiac electrophysiology$133.2M−0.74%
  35. 35IMDXInsight Molecular DiagnosticsMolecular testing for transplanted-organ rejection$129.5M+5.24%
  36. 36SERASeraPreterm-birth risk testing for pregnancy care$81.0M+3.77%
  37. 37STEXStreamexCommodity-tokenization infrastructure and PURE EP electrophysiology$75.0M+7.36%
  38. 38MDXHMDxHealthMolecular prostate-cancer testing menu$30.8M+0.62%
  39. 39QUCYQuantum CyberAutonomous defense drones and counter-UAS systems$30.1M+0.77%
  40. 40BNGOBionano GenomicsOptical genome mapping systems and workflow software$21.0M−3.82%
  41. 41AIFFFirefly NeuroscienceEEG assessment systems for clinical brain-function reports$18.2M+0.81%
  42. 42BNRBurning Rock Biotech (ADR)NGS cancer diagnostics and biopharma testing$15.6M+6.79%
  43. 43CNSYCerenomeCNS cancer diagnostics and targeted radiotherapy$13.1M+6.84%
  44. 44HSCSHeartSciencesAI-enabled ECG workflow platform and diagnostics developer$10.1M+6.41%
  45. 45ADVBAdvanced BiomedFinancial-market AI systems amid biomedical divestiture$8.9M+5.26%
  46. 46BMRABiomericaGI-focused diagnostics and rapid-test maker$8.0M+4.04%
  47. 47CDIOCardio DiagnosticsGenetic-epigenetic blood tests for coronary heart disease$5.7M+1.04%
  48. 48BIAFbioAffinity TechnologiesSputum-based lung diagnostics and pathology services$3.2M+11.69%
  49. 49VNRXVolitionRxNucleosome and chromatin-based blood diagnostics$2.2M−2.53%
  50. 50AMIXAutonomix MedicalTransvascular peripheral-nerve sensing and ablation platform$2.2M+1.23%